AMLN (Amylin Pharmaceuticals, Inc.)
Health Care (Pharmaceuticals and Biotechnology)
Investment Models With Most Exposure In This Sector
|
Manager |
Model |
Sector Exposure |
Since Inception |
Sub. Fee |
|---|
 |
| Sector Focus | Inception Jan 17, 2011 |
The U.S. healthcare industry, particularly Biotech and MedTech, is the core investment universe of my strategy.
 |
| Sector Focus | Inception Oct 06, 2010 |
A portfolio of healthcare companies managed to identify growth and preserve capital with maximum of 20 positions and minimum of 5 …
 |
| Opportunistic | Inception Mar 23, 2011 |
Opportunistic: emphasis on high-tech, Asian ADRs, and beaten-down stocks.
 |
| Opportunistic | Inception Aug 11, 2011 |
This model draws information from the other two models but is not restricted to those sources. Most investment candidates will …
 |
| Market Timing | Inception Dec 13, 2010 |
The model uses quantitative analysis to find short term overbought and oversold conditions in equities.The model has low …
AMLN News
Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
-
Learn about Covestor...
Important Information
- Past performance is no guarantee of future results.
- Performance of the model manager’s account is calculated by Covestor on a daily time-weighted basis, including cash and broker commissions. Manager returns include trades that fail Covestor’s trading rules, do not reflect any Covestor suitability or risk score restrictions and are exclusive of Covestor fees. More
- Month to Date returns and Since Inception returns are revised daily. All other returns (month, 3 month, year to date, et al) are calculated as of the most recent month end date.
- The subscription fee range between 0.5%-2.30% p.a. per subscription to a model. They are subject to a $12.50 minimum per subscription per month, whether or not any trade activity occurs. No subscripition fees are charged on cash that is not subscribed to models
- Benchmark returns have been calculated by Covestor using a time-weighted calculation of daily index valuations and do not include cash or transaction costs.
- All Model Manager information including personal data, profiles, strategies, monthly investment reports, and historical results outside of Covestor has been provided by the Model Manager. Covestor makes no representation or warranty of its accuracy, completeness or relevance and it does not represent the opinions of Covestor. Transaction history is available upon reques.